Melatonin in aging women

References

• Tan DX, Manchester LC, Hardeland R, et al. Melatonin: a hormone, a tissue factor, an autocoid, a paracoid and a antioxidant vitamin. J Pineal Res 2003;34:75–8
   PubMed Web of Science ®Google Scholar
• Dubocovich ML, Markowska M. Functional MT1 and MT2 melatonin receptors in mammals. Endocrine 2005;27:101–10
   PubMed Web of Science ®Google Scholar
• Conti A, Conconi S, Hertens E, Skwarlo-Sonta K, Markowska M, Maestroni JM. Evidence for melatonin synthesis in mouse and human bone marrow cells. J Pineal Res 2000;28:193–202
   PubMed Web of Science ®Google Scholar
• Bellipanni G, Bianchi P, Pierpaoli W, Bulian D, Ilyia E. Effects of melatonin in perimenopausal and menopausal women: a randomized and placebo controlled study. Exp Gerontol 2001;36:297–310
   PubMed Web of Science ®Google Scholar
• Topal T, Öter Ş, Korkmaz A. Melatonin ve kanserle ilişkisi. Genel Tıp Derg 2009;19:137–43
   Google Scholar
• Bergiannaki JD, Soldatos CR, Paparrigopoulos TJ, Syrengelas M, Stefanis CN. Low and high melatonin excretors among healthy individuals. J Pineal Res 1995;18:159–64
   PubMed Web of Science ®Google Scholar
• Waldhauser F, Weissenbacher G, Tatzer E, et al. Alterations in nocturnal serum melatonin levels in human growth and aging. J Clin Endocrinol Metab 1988;66:648–52
   PubMed Web of Science ®Google Scholar
• Karasek M. Melatonin, human aging and age-related diseases. Exp Gerontol 2004;39:1723–9
   PubMed Web of Science ®Google Scholar
• Rohr UD, Herold J. Melatonin deficiencies in women. Maturitas 2002;41(Suppl 2):S85–104
   PubMed Web of Science ®Google Scholar
• Aleandri V, Spina V, Morini A. The pineal gland and reproduction. Hum Reprod Update 1996;2:225–35
   PubMed Web of Science ®Google Scholar
• Fernandez B, Malde Jl, Montero A, Acuña D. Relationship between adenohypophyseal and steroid hormones and variations in serum and urinary melatonin levels during the ovarian cycle, perimenopause and menopause in healthy women. J Steroid Biochem 1990;35:257–62
   PubMedGoogle Scholar
• Toffol E, Kalleinen N, Haukka J, Vakkuri O, Partonen T, Polo-Kantola P. Melatonin in perimenopausal and postmenopausal women: associations with mood, sleep, climacteric symptoms, and quality of life. Menopause 2014;21:493–500
   PubMed Web of Science ®Google Scholar
• Secreto G, Chiechi LM, Amadori A, et al. Soy isoflavones and melatonin for the relief of climacteric symptoms: a multicenter, double-blind, randomized study. Maturitas 2004;47: 11–20
   PubMed Web of Science ®Google Scholar
• Kotlarczyk MP, Lassila HC, O’Neil CK, et al. Melatonin Osteoporosis Prevention Study (MOPS): a randomized, double-blind, placebo-controlled study examining the effects of melatonin on bone health and quality of life in perimenopausal women. J Pineal Res 2012;52:414–26
   PubMed Web of Science ®Google Scholar
• Sanchez-Barcelo EJ, Cos S, Mediavilla D, Martinez-Campa C, Gonzalez A, Alonso-Gonzalez C. Melatonin–estrogen interactions in breast cancer. J. Pineal Res 2005;38:217–22
   PubMed Web of Science ®Google Scholar
• Greenspan SL, Dresner-Pollak R, Parker RA, London D, Ferguson L. Diurnal variation of bone mineral turnover in elderly men and women. Calcif Tissue Int 1997;60:419–23
   PubMed Web of Science ®Google Scholar
• Amstrup AK, Sikjaer T, Mosekilde L, Rejnmark L. Melatonin and the skeleton. Osteoporos Int 2013;24:2919–27
   PubMed Web of Science ®Google Scholar
• Feskanich D, Hankinson SE, Schernhammer ES. Nightshift work and fracture risk: the Nurses’ Health Study. Osteoporos Int 2009;20:537–42
   PubMed Web of Science ®Google Scholar
• Suzuki N, Somei M, Seki A, Reiter RJ, Hattori A. Novel bromomelatonin derivatives as potentially effective drugs to treat bone diseases. J Pineal Res 2008;45:229–34
   PubMed Web of Science ®Google Scholar
• Sánchez-Barceló EJ, Mediavilla MD, Tan DX, Reiter RJ. Clinical uses of melatonin: evaluation of human trials. Curr Med Chem 2010;17:2070–95
   PubMed Web of Science ®Google Scholar
• Slominski RM, Reiter RJ, Schlabritz-Loutsevitch N, Ostrom RS, Slominski AT. Melatonin membrane receptors in peripheral tissues: Distribution and functions. Mol Cell Endocrinol 2012; 351:152–66
   PubMed Web of Science ®Google Scholar
• Zhang L, Su P, Xu C, et al. Melatonin inhibits adipogenesis and enhances osteogenesis of human mesenchymal stem cells by suppressing PPARγ expression and enhancing Runx2 expression. J Pineal Res 2010;49:364–72
   PubMed Web of Science ®Google Scholar
• Egermann M, Gerhardt C, Barth A, Maestroni GJ, Schneider E, Alini M. Pinealectomy affects bone mineral density and structure – an experimental study in sheep. BMC Musculoskelet Disord 2011;12:271
   PubMed Web of Science ®Google Scholar
• Ostrowska Z, Kos-Kudla B, Marek B, et al. The influence of pinealectomy and melatonin administration on the dynamic pattern of biochemical markers of bone metabolism in experimental osteoporosis in the rat. Neuro Endocrinol Lett 2002;23:104–9
   PubMed Web of Science ®Google Scholar
• Dobkin RD, Menza M, Bienfait KL, Allen LA, Marin H, Gara MA. Ramelteon for the treatment of insomnia in menopausal women. Menopause Int 2009;15:13–18
   PubMedGoogle Scholar
• Attarian H, Hachul H, Guttuso T, Phillips B. Treatment of chronic insomnia disorder in menopause: evaluation of literature. Menopause 2015;22:674–84
   PubMed Web of Science ®Google Scholar
• Brzezinski A. Melatonin replacement therapy for postmenopausal women: Is it justified? Menopause 1998;5:60–4
   PubMed Web of Science ®Google Scholar
• Woods NF, Mitchell ES. Symptoms during the perimenopause: prevalence, severity, trajectory, and significance in women’s lives. Am J Med 2005;118:14–24
   PubMed Web of Science ®Google Scholar
• Lavie P. Sleep–wake as a biological rhythm. Annu Rev Psychol 2001;52:277–303
   PubMed Web of Science ®Google Scholar
• Verriest G. [Influence of age on visual functions in humans.] Bull Acad R Med Belg 1971;11:527–78
   PubMedGoogle Scholar
• Herljevic M, Middleton B, Thapan K, Skene DJ. Light-induced melatonin suppression: age-related reduction in response to short wavelength light. Exp Gerontol 2005;40:237–42
   PubMed Web of Science ®Google Scholar
• Reiter RJ. Melatonin: clinical relevance. Best Pract Res Clin Endocrinol Metab 2003;17:273–85
   PubMed Web of Science ®Google Scholar
• Dolev Z. Case series of perimenopausal women with insomnia treated with mirtazapine followed by prolonged-release melatonin add-on and monotherapy. Arch Womens Ment Health 2011;14:269–73
   PubMed Web of Science ®Google Scholar
• Chen WY, Giobbie-Hurder A, Gantman K, et al. A randomized, placebo-controlled trial of melatonin on breast cancer survivors: impact on sleep, mood, and hot flashes. Breast Cancer Res Treat 2014;145:381–8
   PubMed Web of Science ®Google Scholar
• Grin W, Grünberger W. A significant correlation between melatonin deficiency and endometrial cancer. Gynecol Obstet Invest 1998;45:62–5
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Vauhhan MK, Blask DE, Vaughan GM, Johnson LY. The pineal gland: Another perspective. Lancet 1975;1:741
   PubMed Web of Science ®Google Scholar
• Allegra M, Reiter RJ, Tan DX, Gentile C, Tesoriere L, Livrea MA. The chemistry of melatonin's interaction with reactive species. J Pineal Res 2003;34:1–10
   PubMed Web of Science ®Google Scholar
• Cerutti P, Ghosh R, Oya Y, Amstad P. The role of the cellular antioxidant defense in oxidant carcinogenesis. Environ Health Perspect 1994;102:123–9
   PubMed Web of Science ®Google Scholar
• Blask DE, Dauchy RT, Sauer LA, Krause JA. Melatonin uptake and growth prevention in rat hepatoma 7288 CTC in response to dietary melatonin: melatonin receptor-mediated inhibition of tumor linoleic acid metabolism to the growth signaling molecule 13-hydroxydecadienoic acid and the potential role of phytomelatonin. Carcinogenesis 2004;25:951–60
   PubMed Web of Science ®Google Scholar
• Leon-Blanco MM, Guerrero JM, Reiter RJ, Calvo JR, Pozo D. Melatonin inhibits telomerase activity in the MCF-7 tumor cell line both in vivo and in vitro. J Pineal Res 2003;35: 204–11
   PubMed Web of Science ®Google Scholar
• Kilic E, Kilic U, Reiter RJ, Bassetti CL, Hermann DM. Prophylactic use of melatonin protects against focal cerebral ischemia in mice: role of endothelin converting enzyme-1. J Pineal Res 2004;37:247–51
   PubMed Web of Science ®Google Scholar
• Feychting M, Osterlund B, Ahlbom A. Reduced cancer incidence among the blind. Epidemiology 1998;9:490–4
   PubMed Web of Science ®Google Scholar
• Deming SL, Lu W, Beeghly-Fadiel A, et al. Melatonin pathway genes and breast cancer risk among Chinese women. Breast Cancer Res Treat 2012;132:693–9
   PubMed Web of Science ®Google Scholar
• Schernhammer ES, Berrino F, Krogh V, et al. Urinary 6-sulfatoxymelatonin levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 2008;100:898–905
   PubMed Web of Science ®Google Scholar
• Travis RC, Allen DS, Fentiman IS, Key TJ. Melatonin and breast cancer: a prospective study. J Natl Cancer Inst 2004;96: 475–82
   PubMed Web of Science ®Google Scholar
• Nagata C, Nagao Y, Yamamoto S, Shibuya C, Kashiki Y, Shimizu H. Light exposure at night, urinary 6-sulfatoxymelatonin, and serum estrogens and androgens in postmenopausal Japanese women. Cancer Epidemiol Biomarkers Prev 2008; 17:1418–23
   PubMed Web of Science ®Google Scholar
• Greenlee H, Hershman DL, Jacobson JS. Use of antioxidant supplements during breast cancer treatment: a comprehensive review. Breast Cancer Res Treat 2009;115:437–52
   PubMed Web of Science ®Google Scholar
• Kanishi Y, Kobayashi Y, Noda S, Saito K, Ishizuka B. Differential growth inhibitory effect of melatonin on two endometrial cancer cell lines. J Pineal Res 2000;28:227–33
   PubMed Web of Science ®Google Scholar
• Duell PB, Wheaton DL, Shultz A, Nguyen H. Inhibition of LDL oxidation by melatonin requires supraphysiologic concentrations. Clin Chem 1998;44:1931–6
   PubMed Web of Science ®Google Scholar
• Carranza-Lira S, García López F. Melatonin and climactery. Med Sci Monit 2000;6:1209–12
   PubMedGoogle Scholar
• Ciortea R, Costin N, Braicu I, et al. Effect of melatonin on intra-abdominal fat in correlation with endometrial proliferation in ovariectomized rats. Anticancer Res 2011;31:2637–43
   PubMed Web of Science ®Google Scholar
• Hoang BX, Shaw DG, Pham PT, Levine SA. Neurobiological effects of melatonin as related to cancer. Eur J Cancer Prev 2007;16:511–16
   PubMed Web of Science ®Google Scholar
• Guerrero JM, Reiter RJ. Melatonin-immune system relationships. Curr Top Med Chem 2002;2:167–79
   PubMedGoogle Scholar
• Carrillo-Vico A, Calvo JR, Abreu P, et al. Evidence of melatonin synthesis by human lymphocytes and its physiological significance: possible role as intracrine, autocrine, and/or paracrine substance. FASEB J 2004;18:537–9
   PubMed Web of Science ®Google Scholar
• Szczepanik M. Melatonin and its influence on immune system. J Physiol Pharmacol 2007;58:6:115–24
   PubMed Web of Science ®Google Scholar
• Shaji AV, Kulkarni SK, Agrewala JN. Regulation of secretion of IL-4 and IgG1 isotype by melatonin-stimulated ovalbumin- specific T cells. Clin Exp Immunol 1998;111:181–5
   PubMed Web of Science ®Google Scholar
• De la Fuente M. Role of neuroimmunomodulation in aging. Neuroimmunomodulation 2008;15:213–23
   PubMed Web of Science ®Google Scholar
• De la Fuente M, Baeza, I, Guayerbas N, et al. Changes with ageing in several leukocyte functions of male and female rats. Biogerontology 2004;5:389–400
   PubMed Web of Science ®Google Scholar
• Baeza I, Alvarado C, Alvarez P, et al. Improvement of leucocyte functions in ovariectomised aged rats after treatment with growth hormone, melatonin, oestrogens or phyto-oestrogens. J Reprod Immunol 2009;80:70–9
   PubMed Web of Science ®Google Scholar
• Baeza I, Fdez-Tresguerres J, Ariznavarreta C, De la Fuente M. Effects of growth hormone, melatonin, oestrogens and phytoestrogens on the oxidized glutathione (GSSG)/reduced glutathione (GSH) ratio and lipid peroxidation in aged ovariectomized rats. Biogerontology 2010;11:687–701
   PubMed Web of Science ®Google Scholar
• Di Blasio A, Bucci I, Ripari P, et al. Lifestyle and high density lipoprotein cholesterol in postmenopause. Climacteric 2014;17: 37–47
   PubMed Web of Science ®Google Scholar
• Polotsky HN, Polotsky AJ. Metabolic implications of menopause. Semin Reprod Med 2010;28:426–34
   PubMed Web of Science ®Google Scholar
• Chan TY, Tang PL. Effect of melatonin on the maintenance of cholesterol homeostasis in the rat. Endocr Res 1995;21: 681–96
   PubMed Web of Science ®Google Scholar
• Hall ES, Lynch GR. Two daily melatonin injections differentially induce nonshivering thermogenesis and gonadal regression in the mouse (Peromyscus leucopus). Life Sci 1985;37:783–8
   PubMed Web of Science ®Google Scholar
• Barzilai N, Wang J, Massilon D, Vuguin P, Hawkins M, Rossetti L. Leptin selectively decreases visceral adiposity and enhances insulin action. J Clin Invest 1997;100:3105–10
   PubMed Web of Science ®Google Scholar
• Lee JY, Lee DC. Urine 6-sulfatoxymelatonin levels are inversely associated with arterial stiffness in post-menopausal women. Maturitas 2014;78:117–22
   PubMed Web of Science ®Google Scholar
• Wakatsuki A, Ikenoue N, Okatani Y, Izumiya C, Kaneda C. Melatonin inhibits oxidative modification of low density lipoprotein particles in postmenopausal women with normolipidemia. J Pineal Res 2000;28:136–42
   PubMed Web of Science ®Google Scholar
• Wakatsuki A, Okatani Y, Ikenoue N, Kaneda C, Fukaya T. Effects of short-term melatonin administration on lipoprotein metabolism in normolipidemic postmenopausal women. Maturitas 2001;38:171–7
   PubMed Web of Science ®Google Scholar
• Hussein MR, Ahmed OG, Hassan AF, Ahmed MA. Intake of melatonin is associated with amelioration of physiological changes, both metabolic and morphological pathologies associated with obesity: an animal model. Int J Exp Pathol 2001;88: 19–29
   Web of Science ®Google Scholar
• Baxi D, Singh PK, Vachhrajani K, Ramachandran AV. Melatonin supplementation therapy as a potent alternative to ERT in ovariectomized rats. Climacteric 2012;15:382–92
   PubMed Web of Science ®Google Scholar
• Cagnacci A, Arangino S, Renzi A, et al. Influence of melatonin administration on glucose tolerance and insulin sensitivity of postmenopausal women. Clin Endocrinol (Oxf) 2001;54: 339–46
   PubMed Web of Science ®Google Scholar